Industry Pulse › What the Peptide Sciences Shutdown Revealed May 23, 2026 · Research In March 2026, Peptide Sciences voluntarily ceased operations. The company had been one of the largest U.S. research peptide suppliers for more than a decade, with an estimated $7.4 million in monthly revenue and a customer base spanning academic laboratories, independent …

A research team at Helmholtz Zentrum München has published the design of a single-molecule quintuple agonist that activates GLP-1, GIP, and three PPAR receptor subtypes. Published in Nature on April 30, 2026, the conjugate outperformed semaglutide and tirzepatide dual agonism in obese diabetic mouse models.